137 related articles for article (PubMed ID: 10644985)
21. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
[TBL] [Abstract][Full Text] [Related]
22. AML1(-/-) embryos do not express certain hematopoiesis-related gene transcripts including those of the PU.1 gene.
Okada H; Watanabe T; Niki M; Takano H; Chiba N; Yanai N; Tani K; Hibino H; Asano S; Mucenski ML; Ito Y; Noda T; Satake M
Oncogene; 1998 Nov; 17(18):2287-93. PubMed ID: 9811459
[TBL] [Abstract][Full Text] [Related]
23. Core-binding factor: a central player in hematopoiesis and leukemia.
Speck NA; Stacy T; Wang Q; North T; Gu TL; Miller J; Binder M; Marín-Padilla M
Cancer Res; 1999 Apr; 59(7 Suppl):1789s-1793s. PubMed ID: 10197598
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional regulation of angiogenesis-related puromycin-insensitive leucyl-specific aminopeptidase in endothelial cells.
Niizeki O; Miyashita H; Yamazaki T; Akada T; Abe M; Yoshida N; Watanabe T; Yoshimatsu H; Sato Y
Arch Biochem Biophys; 2004 Apr; 424(1):63-71. PubMed ID: 15019837
[TBL] [Abstract][Full Text] [Related]
25. Homologs of RUNX and CBF beta/PEBP2 beta in C. elegans.
Lee J; Ahnn J; Bae SC
Oncogene; 2004 May; 23(24):4346-52. PubMed ID: 15156192
[TBL] [Abstract][Full Text] [Related]
26. Modulation of angiogenesis and tumorigenicity of human melanocytic cells by vascular endothelial growth factor and basic fibroblast growth factor.
Graeven U; Rodeck U; Karpinski S; Jost M; Philippou S; Schmiegel W
Cancer Res; 2001 Oct; 61(19):7282-90. PubMed ID: 11585767
[TBL] [Abstract][Full Text] [Related]
27. The cDNA cloning of the transcripts of human PEBP2alphaA/CBFA1 mapped to 6p12.3-p21.1, the locus for cleidocranial dysplasia.
Zhang YW; Bae SC; Takahashi E; Ito Y
Oncogene; 1997 Jul; 15(3):367-71. PubMed ID: 9233771
[TBL] [Abstract][Full Text] [Related]
28. [PEBP2/CBF/AML1: master regulators for tissue specific gene expression].
Ito Y
Tanpakushitsu Kakusan Koso; 2000 Jan; 45(1):1-6. PubMed ID: 10643328
[No Abstract] [Full Text] [Related]
29. Identification of the region of mi transcription factor which is responsible for the synergy with PEBP2/CBF.
Morii E; Ogihara H; Kanno T; Kim DK; Nomura S; Ito Y; Kitamura Y
Biochem Biophys Res Commun; 1999 Jul; 261(1):53-7. PubMed ID: 10405322
[TBL] [Abstract][Full Text] [Related]
30. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
[TBL] [Abstract][Full Text] [Related]
31. Solution structure of core binding factor beta and map of the CBF alpha binding site.
Huang X; Peng JW; Speck NA; Bushweller JH
Nat Struct Biol; 1999 Jul; 6(7):624-7. PubMed ID: 10404216
[TBL] [Abstract][Full Text] [Related]
32. Identification of an angiogenic mitogen selective for endocrine gland endothelium.
LeCouter J; Kowalski J; Foster J; Hass P; Zhang Z; Dillard-Telm L; Frantz G; Rangell L; DeGuzman L; Keller GA; Peale F; Gurney A; Hillan KJ; Ferrara N
Nature; 2001 Aug; 412(6850):877-84. PubMed ID: 11528470
[TBL] [Abstract][Full Text] [Related]
33. HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis.
Fang J; Yan L; Shing Y; Moses MA
Cancer Res; 2001 Aug; 61(15):5731-5. PubMed ID: 11479208
[TBL] [Abstract][Full Text] [Related]
34. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
[TBL] [Abstract][Full Text] [Related]
35. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma.
Shi Q; Le X; Abbruzzese JL; Peng Z; Qian CN; Tang H; Xiong Q; Wang B; Li XC; Xie K
Cancer Res; 2001 May; 61(10):4143-54. PubMed ID: 11358838
[TBL] [Abstract][Full Text] [Related]
36. [CBFA1/PEBP2 alpha A].
Komori T
Nihon Rinsho; 1998 Jun; 56(6):1430-4. PubMed ID: 9648460
[TBL] [Abstract][Full Text] [Related]
37. Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain.
Nagata T; Gupta V; Sorce D; Kim WY; Sali A; Chait BT; Shigesada K; Ito Y; Werner MH
Nat Struct Biol; 1999 Jul; 6(7):615-9. PubMed ID: 10404214
[TBL] [Abstract][Full Text] [Related]
38. [Pebp2 alpha A/Cbfa1 is a master regulator of bone formation].
Komori T
Tanpakushitsu Kakusan Koso; 2000 Jan; 45(1):13-7. PubMed ID: 10643330
[No Abstract] [Full Text] [Related]
39. PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials.
Bae SC; Ogawa E; Maruyama M; Oka H; Satake M; Shigesada K; Jenkins NA; Gilbert DJ; Copeland NG; Ito Y
Mol Cell Biol; 1994 May; 14(5):3242-52. PubMed ID: 8164679
[TBL] [Abstract][Full Text] [Related]
40. Regulation mechanisms for the heterodimeric transcription factor, PEBP2/CBF.
Bae SC; Ito Y
Histol Histopathol; 1999 Oct; 14(4):1213-21. PubMed ID: 10506937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
